TherapeuticsMD Balance Sheet Health
Financial Health criteria checks 4/6
TherapeuticsMD has a total shareholder equity of $29.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $43.3M and $14.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$4.33m |
Equity | US$29.29m |
Total liabilities | US$14.02m |
Total assets | US$43.31m |
Recent financial health updates
Recent updates
TherapeuticsMD raises $7M in private placement
Oct 03TherapeuticsMD appoints interim co-CEOs
Sep 12Therapeutics MD Q2 Earnings Preview
Aug 12TherapeuticsMD receives $15M equity investment from Rubric Capital
Aug 01TherapeuticsMD jumps 12% as top investor discloses insider purchase
Jul 19TherapeuticsMD plunges 42% as merger agreement ends
Jul 13TherapeuticsMD risks bankruptcy as EW Healthcare extends tender offer for acquisition
Jul 06TherapeuticsMD: Privatization Deal Expected To Meet With Shareholder Pushback
Jun 16TherapeuticsMD: Looking For A Potential Turnaround After Divesting VitaCare Business
Mar 14TherapeuticsMD: Time For Bulls To Take A Contrarian Approach
Oct 22TherapeuticsMD: The Long Road To Profitability
Jul 08TherapeuticsMD drops 3% despite consensus beating Q1 results
May 06TherapeuticsMD, Inc. (NASDAQ:TXMD): Are Analysts Optimistic?
Feb 24TherapeuticsMD: Annovera May Save The Day
Feb 04TherapeuticsMD, Inc. (NASDAQ:TXMD) Analysts Are More Bearish Than They Used To Be
Jan 29What Type Of Shareholders Make Up TherapeuticsMD, Inc.'s (NASDAQ:TXMD) Share Registry?
Jan 27Have Insiders Been Buying TherapeuticsMD, Inc. (NASDAQ:TXMD) Shares?
Dec 30TherapeuticsMD (NASDAQ:TXMD) Share Prices Have Dropped 87% In The Last Five Years
Dec 09TherapeuticsMD: Q3 Report Reveals Strong Rebound And Bolsters Commercial Outlook
Nov 25Therapeutics MD EPS beats by $0.01, beats on revenue
Nov 09Financial Position Analysis
Short Term Liabilities: TXMD's short term assets ($11.8M) exceed its short term liabilities ($6.9M).
Long Term Liabilities: TXMD's short term assets ($11.8M) exceed its long term liabilities ($7.2M).
Debt to Equity History and Analysis
Debt Level: TXMD is debt free.
Reducing Debt: TXMD has no debt compared to 5 years ago when its debt to equity ratio was 75.2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if TXMD has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if TXMD has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.